Skip to main content
SpringerLink
Log in

Process analytical technologies in the pharmaceutical industry: the FDA’s PAT initiative

  • Feature Article
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Workman J, Koch M, Veltkamp DJ (2003) Anal Chem 75(12):2859–2876

    Article  CAS  Google Scholar 

  2. Lavine B, Workman JJ (2004) Anal Chem 76(12):3365–3372

    Article  PubMed  CAS  Google Scholar 

  3. Harre M, Tilstam U, Weinmann H (1999) Org Process Res Dev 3(5):304–318

    Article  CAS  Google Scholar 

  4. Hinz DC (2004) PAT—J Process Anal Technol 1(2):16–18

    CAS  MathSciNet  Google Scholar 

  5. Balboni ML (2003) Pharm Technol (North Am) 27(10):54–66, 254

    Google Scholar 

  6. Paulson W (ed) (2002) Gold Sheet 36(2):10

    Google Scholar 

  7. Lyon RC, Jefferson EH, Ellison CD, Buhse LF, Spencer JA, Nasr MM, Hussain AS (2003) Am Pharm Rev 6(3):62–70

    CAS  Google Scholar 

  8. DiMasi JA, Hansen RW, Grabowski HG (2003) J Health Econ 22:151–185

    Article  PubMed  Google Scholar 

  9. Pharmaceutical Research and Manufacturers of America (PhRMA) (2004). Pharmaceutical industry profile 2004. PhRMA, Washington, DC; http://www.phrma.org

  10. Pelletier B (2004) Pharm Process 21(10):84–88

    Google Scholar 

  11. Wechsler J (2002) Pharm Technol North Am 26(2):16–24

    MathSciNet  Google Scholar 

  12. Abboud L, Hensley S (2003) Factory shift—new prescription for drug makers: update the plants. Wall Street Journal , p 1, A6

  13. Miller RW (2002) Am Pharm Rev 5(2):25–29

    Google Scholar 

  14. Miller RW (2003) Am Pharm Rev 6(1):52–61

    Google Scholar 

  15. Sherman RE (2005) The role of spectroscopy in process analytical technologies, supplement to spectroscopy, vol 20, no 1, pp 11–13

  16. Koch MV, Marquardt BJ (2004) PAT—J Process Anal Technol 1(2):12–15

    CAS  Google Scholar 

  17. Paulson W (ed) (2003) Gold Sheet 37(6):10

    Google Scholar 

  18. U.S. Department of Health and Human Services, Food and Drug Administration (2004) Guidance for industry: PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. http://www.fda.gov/cder/guidance/6419fnl.pdf

    Google Scholar 

  19. Shanley A (2004) Pharm Manuf 6:41–45

    Google Scholar 

  20. Rubric News Spectrum (2005) Market profile—on-line spectroscopy and PAT. Spectroscopy 20(1):12

    Google Scholar 

  21. Bakeev KA (2003) Pharm Technol Eur 15(9):27–32

    CAS  Google Scholar 

  22. Afnan AM (2004) PAT—J Process Anal Technol 1 (1):8–9

    Google Scholar 

  23. Paulson W (ed) (2003) Gold Sheet 37(6):5

    Google Scholar 

  24. Cini P, Schneider RE (2004) Pharm Exec 24(3):86–95

    Google Scholar 

  25. Paulson B (ed) (2004) Gold Sheet 38(6):1–23

    Google Scholar 

  26. http://www.emea.eu.int/Inspections/PAThome.html

  27. Gaffner C (2004) Medical Products Agency, Uppsala, Sweden, presentation. Regulatory milestones in EU with respect to PAT, presentation given at a training course for EU inspectors and quality assessors organised by the Swedish Medical Products Agency in collaboration with EMEA in September 2004; http://www.emea.eu.int/Inspections/docs/PAT%20Uppsala%20040923.pdf

  28. Paulson B (ed) (2004) Gold Sheet 38(7):1–19

    Google Scholar 

  29. http://www.astm.org/cgi-bin/SoftCart.exe/COMMIT/COMMITTEE/E55. htm?L+mystore+ofnn3447

  30. Paulson W (ed) (2003) Gold Sheet 37(6):7

    Google Scholar 

  31. Fischer G (2005) Sanofi-Aventis, Kansas City, MO. Experiences from a PAT pilot project, presentation at the 19th international forum process analytical technology (Process Analysis& Control)—IFPAC 2005; January 10–13, 2005, Arlington, Virginia (Washington, DC)

  32. Paulson B (ed) (2004) Gold Sheet 38(11):7

    Google Scholar 

  33. D’Sa AM (2005) Office of Compliance, DMPQ CDER, FDA. Process analytical technology (PAT): regulatory process, review and inspection; presentation at the 19th international forum process analytical technology (Process Analysis& Control)—IFPAC 2005; January 10–13, 2005, Arlington, Virginia (Washington, DC)

    Google Scholar 

  34. Paulson B (ed) (2004) Gold Sheet 38(10):15

    Google Scholar 

  35. Radspinner D (2005) Sanofi-Aventis, Kansas City, MO. Implementing PAT—industry example, presentation at the 19th international forum process analytical technology (Process Analysis& Control)—IFPAC 2005; January 10–13, 2005, Arlington, Virginia (Washington, DC)

Download references

Author information

Authors and Affiliations

  1. Process Control Department, Schering AG, Global CMC Development, 13342, Berlin, Germany

    Dirk C. Hinz

Authors
  1. Dirk C. Hinz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk C. Hinz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hinz, D.C. Process analytical technologies in the pharmaceutical industry: the FDA’s PAT initiative. Anal Bioanal Chem 384, 1036–1042 (2006). https://doi.org/10.1007/s00216-005-3394-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-005-3394-y

Keywords

Search

Navigation